|

Trastuzumab plus Pertuzumab (combination) Clinical Trials

1 actively recruiting trial

Also known as: Herceptin plus Perjeta (combination)

Pipeline

Phase 2: 1

Top Sponsors

  • Ulrik Lassen1

Indications

  • Neoplasia1
  • Tumors1
  • Neoplasms1
  • Cancer1

Other1 trial

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.